EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

Mar 10

Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.

The current Board comprises: • Chairman and Executive Director: Yifang Wu • Executive Directors: Yongqing Luo, Ian Ying Woo • Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun • Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang

The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1127952348"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127952348\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127952348?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127952348","market":"us","top_or_hot":-1,"title":"EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results","media":"Bulletin Express","content":"<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1127952348","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127952348","pubTimestamp":1773133437,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"EVEREST MED(01952)定于2026年3月25日召开董事会批准2025财年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.\nThe current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang\nThe announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}